These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 31511498)
1. Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response. Lin S; Yu L; Song X; Bi J; Jiang L; Wang Y; He M; Xiao Q; Sun M; Olopade OI; Zhao L; Wei M Cell Death Dis; 2019 Sep; 10(9):666. PubMed ID: 31511498 [TBL] [Abstract][Full Text] [Related]
2. The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells. Yao C; Du W; Chen H; Xiao S; Huang L; Chen F Leuk Lymphoma; 2015 Mar; 56(3):755-62. PubMed ID: 24996439 [TBL] [Abstract][Full Text] [Related]
3. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer. Chang L; Hu Z; Zhou Z; Zhang H Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527 [TBL] [Abstract][Full Text] [Related]
4. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells. Li Y; Zhao L; Sun H; Yu J; Li N; Liang J; Wang Y; He M; Bai X; Yu Z; Zheng Z; Mi X; Wang E; Wei M PLoS One; 2012; 7(8):e44254. PubMed ID: 22952942 [TBL] [Abstract][Full Text] [Related]
5. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway. Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366 [TBL] [Abstract][Full Text] [Related]
6. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1. Long X; Lin XJ J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173 [TBL] [Abstract][Full Text] [Related]
7. RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation. He M; Sun HG; Hao JY; Li YL; Yu JK; Yan YY; Zhao L; Li N; Wang Y; Bai XF; Yu ZJ; Zheng ZH; Mi XY; Wang EH; Wei MJ Oncol Rep; 2013 May; 29(5):1721-9. PubMed ID: 23440494 [TBL] [Abstract][Full Text] [Related]
8. The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells. Zhao L; Li Y; He M; Song Z; Lin S; Yu Z; Bai X; Wang E; Wei M Int J Oncol; 2014 Jul; 45(1):129-38. PubMed ID: 24789349 [TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin. Qi X; Chang Z; Song J; Gao G; Shen Z Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162 [TBL] [Abstract][Full Text] [Related]
10. Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells. Fang Y; Shen H; Cao Y; Li H; Qin R; Chen Q; Long L; Zhu XL; Xie CJ; Xu WL Braz J Med Biol Res; 2014 Jan; 47(1):60-9. PubMed ID: 24519092 [TBL] [Abstract][Full Text] [Related]
11. Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway. Huang Q; Wu YY; Xing SJ; Yu ZW Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5285-5292. PubMed ID: 31298380 [TBL] [Abstract][Full Text] [Related]
12. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells. Hu D; Li M; Su J; Miao K; Qiu X Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway. Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474 [TBL] [Abstract][Full Text] [Related]
14. Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia. Yao C; Du W; Chen H; Xiao S; Huang L; Chen FP Mol Med Rep; 2015 Jun; 11(6):4605-10. PubMed ID: 25647473 [TBL] [Abstract][Full Text] [Related]
15. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27 Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1. Li XJ; Ji MH; Zhong SL; Zha QB; Xu JJ; Zhao JH; Tang JH Arch Med Res; 2012 Oct; 43(7):514-21. PubMed ID: 23085450 [TBL] [Abstract][Full Text] [Related]
17. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts. Kim TH; Kim HS; Kang YJ; Yoon S; Lee J; Choi WS; Jung JH; Kim HS Biochim Biophys Acta; 2015 Feb; 1850(2):401-10. PubMed ID: 25445714 [TBL] [Abstract][Full Text] [Related]
18. miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1. Gao M; Miao L; Liu M; Li C; Yu C; Yan H; Yin Y; Wang Y; Qi X; Ren J Oncotarget; 2016 Sep; 7(37):59714-59726. PubMed ID: 27487127 [TBL] [Abstract][Full Text] [Related]
20. MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1). Zhao L; Wang Y; Jiang L; He M; Bai X; Yu L; Wei M J Exp Clin Cancer Res; 2016 Feb; 35():25. PubMed ID: 26842910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]